Hsbc Holdings PLC Chemo Centryx, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $6 Million - $14 Million
270,839 New
270,839 $14 Million
Q1 2021

May 14, 2021
SELL
$49.53 - $68.4 $223,132 - $308,142
-4,505 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$47.25 - $65.16 $212,861 - $293,545
4,505 New
4,505 $278,000
Q4 2019

Feb 14, 2020
SELL
$6.81 - $39.55 $241,428 - $1.4 Million
-35,452 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$6.47 - $8.96 $229,374 - $317,649
35,452 New
35,452 $240,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email